Heart defects may stunt growth in infants, new study to investigate
NCT ID NCT07373873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will review medical records of 72 children aged 1 month to 2 years with congenital heart disease (CHD) to see how their growth compares to healthy children. Researchers will measure weight, height, and head circumference. The goal is to understand which types of CHD affect growth most, helping doctors improve nutrition and care for these children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of infants and young children (aged 1 month to 2 years) who were diagnosed with congenital heart disease (CHD) by echocardiography and were followed at the Pediatric Cardiology Unit of Assiut University Children Hospital. This is a retrospective cohort; participants are identified through a review of existing hospital medical records. The population includes patients with various types of CHD (both cyanotic and acyanotic) who have not yet undergone corrective cardiac surgery or intervention.
- Ages
-
1 month to 2 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 1 month to 2 years. * Diagnosis of congenital heart disease (CHD) confirmed by echocardiography. * Availability of anthropometric data in the medical record. Exclusion Criteria: * Presence of a known genetic syndrome or major extracardiac anomalies. * Pre-existing endocrine or metabolic disorder affecting growth. * Preterm birth (gestational age \<37 weeks). * Previous surgical/interventional procedure for CHD.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital heart disease (CHD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Assuit University Children Hospital
Asyut, 71515, Egypt
-
Assuit University Children Hospital - Cardiology Department
Asyut, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robotic magnetic catheter takes aim at stubborn heart rhythms in adults born with heart defects
- A second chance for the thymus: could reimplanting it during heart surgery shield immunity?
- Could waiting longer to clamp the cord boost outcomes for babies with heart defects?
- AI reads heart scans to predict which children will develop serious complications
- Play therapy may calm young heart patients before surgery
- Stem cells given during infant heart surgery: a safety first